Related Experiment Video
Updated: Nov 27, 2025

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Pathologic Features of Anti-Mi-2 Dermatomyositis
Jantima Tanboon1, Michio Inoue1, Shinya Hirakawa1
1From Department of Neuromuscular Research (J.T., M.I., S. Hayashi, S.N., I.N.), National Institute of Neuroscience, Departments of Genome Medicine Development (J.T., M.I., S. Hayashi, S.N., I.N.) and Clinical Genome Analysis (I.N.), Medical Genome Center, and Department of Clinical Epidemiology (S. Hirakawa, H.T.), Translational Medical Center, National Center of Neurology and Psychiatry; Department of Neurology (S.S.), Keio University School of Medicine, Tokyo; Department of Dermatology (N.O., M.F.), Faculty of Medicine, University of Tsukuba, Ibaraki; and Department of Dermatology (M.F.), Graduate School of Medicine, Osaka University, Japan.
Patients with anti-Mi-2 dermatomyositis (DM) exhibit more severe muscle fiber and inflammatory pathology. These findings highlight shared features with anti-synthetase syndrome (ASS), suggesting overlapping disease mechanisms.
Area of Science:
- Rheumatology
- Neurology
- Immunology
Background:
- Dermatomyositis (DM) is an idiopathic inflammatory myopathy.
- Anti-Mi-2 autoantibodies are associated with a specific DM subtype.
- Understanding the distinct pathological features of anti-Mi-2 DM is crucial for diagnosis and management.
Purpose of the Study:
- To identify the characteristic pathologic features of DM associated with anti-Mi-2 autoantibodies.
- To compare these features with non-Mi-2 DM and anti-synthetase syndrome (ASS).
Main Methods:
- Review of 188 muscle biopsies from DM patients.
- Categorization based on anti-Mi-2 autoantibodies, other DM-specific autoantibodies (DMSAs), or DMSA-negative status.
- Histopathologic and immunohistochemical analysis with statistical comparisons (t test, Fisher exact test, logistic regression).
Main Results:
- Anti-Mi-2 DM patients showed significantly higher severity scores in muscle fiber and inflammatory domains compared to non-Mi-2 DM patients.
- Perifascicular necrosis, increased perimysial alkaline phosphatase, and membrane attack complex deposition were more frequent in anti-Mi-2 DM.
- No significant differences in these features were found between anti-Mi-2 DM and ASS after Bonferroni correction.
Conclusions:
- Perifascicular necrosis and perimysial pathology are common in anti-Mi-2 DM, similar to ASS.
- These findings aid in differentiating anti-Mi-2 DM from other DM subtypes.
- The study suggests potential overlapping pathogenic mechanisms between anti-Mi-2 DM and ASS.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Endocarditis II: Clinical Features of Infective Endocarditis
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Desmosomes

